← Leaderboards
David J Milan
Massachusetts General Hospital
$6,100,897
Attributed
$7,606,063
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,606,063 · 6
By mechanism
R01$5,681,705 · 3
R21$1,262,858 · 2
K08$661,500 · 1
Top collaborators
- Susan A Slaugenhaupt4 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Robert A Levine$14,709,794
- Changning Wang$11,415,964
- Anders M Naar$8,178,903
- Stephen N. Gomperts$8,663,513
- David Kokel$3,289,433
Others in their field
Top investigators on “Zebrafish”
- Leonard I Zon · Children'S Hospital Boston$58,820,730
- Monte Westerfield · University Of Oregon$50,217,878
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Karl Alexander Deisseroth · Stanford University$29,745,200
- William S Talbot · Stanford University$29,496,829
- Robert L Tanguay · Oregon State University$27,361,484
Research focus
ZebrafishGenesArrhythmiaGeneticPlayCellsResponseCardiacProteinsPharmaceutical PreparationsMutationEventMolecularAnimal ModelElectrocardiogramElectrophysiology (Science)LeadAffectLaboratoriesLong Qt SyndromeAction PotentialsComplexIn VitroMaps
Grant awards (18)
Genetics and Mechanisms of Mitral Valve Prolapse$750,072
R01 · FY2018 · HL
Genetics and Mechanisms of Mitral Valve Prolapse$758,841
R01 · FY2017 · HL · contact PI
Novel Therapy for Long QT Syndrome$606,582
R01 · FY2017 · HL · contact PI
Genetics and Mechanisms of Mitral Valve Prolapse$727,787
R01 · FY2016 · HL · contact PI
Novel Therapy for Long QT Syndrome$601,995
R01 · FY2016 · HL · contact PI
Genetics and Mechanisms of Mitral Valve Prolapse$773,633
R01 · FY2015 · HL · contact PI
High Throughput Screening for Chemical Modifiers of Long QT Syndrome$397,409
R01 · FY2013 · HL · contact PI
High Throughput Screening for Chemical Modifiers of Long QT Syndrome$441,911
R01 · FY2012 · HL · contact PI
High Throughput Screening for Chemical Modifiers of Long QT Syndrome$623,475
R01 · FY2011 · HL · contact PI
Electrical Silencing of the Pulmonary Veins$220,182
R21 · FY2011 · HL · contact PI
The Genetic Basis of Novel Loci Influencing Myocardial Repolarization$329,569
R21 · FY2010 · DA · contact PI
Electrical Silencing of the Pulmonary Veins$263,278
R21 · FY2010 · HL · contact PI
The Genetic Basis of Novel Loci Influencing Myocardial Repolarization$449,829
R21 · FY2009 · DA · contact PI
A Molecular Study of Cardiac Repolarization$132,300
K08 · FY2009 · HL · contact PI
A Molecular Study of Cardiac Repolarization$132,300
K08 · FY2008 · HL · contact PI
A Molecular Study of Cardiac Repolarization$132,300
K08 · FY2007 · HL · contact PI
A Molecular Study of Cardiac Repolarization in Zebrafish$132,300
K08 · FY2006 · HL · contact PI
A Molecular Study of Cardiac Repolarization in Zebrafish$132,300
K08 · FY2005 · HL